Filing Details
- Accession Number:
- 0000950170-25-040600
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-17 19:07:42
- Reporting Period:
- 2025-03-17
- Filing Date:
- 2025-03-17
- Accepted Time:
- 2025-03-17 19:07:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339970 | Atyr Pharma Inc | ATYR | Biological Products, (No Disgnostic Substances) (2836) | 203435077 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1684258 | A Jane Gross | C/O Atyr Pharma, Inc. 10240 Sorrento Valley Road, Suite 300 San Diego CA 92121 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-17 | 3,750 | $4.00 | 9,750 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
